Purpose: to deobligate remaining fiscal year 2015 funding in preparation for the september 30, 2020 closing of the period of availability of these fiscal year funds.
Ended Purchase Order Awarded Last action
- Contract number
- HHSN271201500052A
- Awardee
-
Cyprotex US LLC UEI YNGLSAF57T14
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $80,000
Award facts
- Contract value 100% obligated
- $80,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$220,000 | |
| Original award | $300,000 |
About this award
This is a firm-fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the U.S. Department of Health and Human Services (HHS), to Cyprotex US LLC, a foreign-owned, for-profit contract research organization. The $80,000 contract is for the provision of testing services for 30 compounds, including conducting cytochrome P450 (CYP) inhibition testing, Caco-2 permeability assays, and other absorption, distribution, metabolism, and excretion (ADME)-related services. The award has no set-aside designation and was not associated with a larger contract vehicle. Cyprotex US LLC has a history of providing specialized testing services to various federal agencies, including the Environmental Protection Agency (EPA), HHS, National Institutes of Health (NIH), and Department of Veterans Affairs (VA), to support chemical risk assessment, drug development, and environmental research programs.
Quick answers
Who was awarded contract HHSN271201500052A?
HHSN271201500052A was awarded to Cyprotex US LLC by National Institute on Drug Abuse (National Institutes of Health) on August 21, 2015.
How much is contract HHSN271201500052A worth?
The government has obligated $80,000 on HHSN271201500052A.
Which agency awarded contract HHSN271201500052A?
National Institute on Drug Abuse (National Institutes of Health) awarded HHSN271201500052A, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract HHSN271201500052A competed?
The extent of competition for HHSN271201500052A was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award